Company Analysis

TScan Therapeutics, Inc. (TCRX)

Nasdaq: TCRX · Biological Products, (No Diagnostic Substances) · Waltham, MA · filing with the SEC since 2019
Grade4.7
◀ Past 3.9● Present 3.4▶ Future 6.3
1 est.

Filings

215 filings since 2017 beside 121 insider forms · and emerging growth company · read from EDGAR on Nov 13, 2026
Due next and emerging growth company
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by May 15, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 43 days after the quarter ended. The proxy statement was last filed Oct 26, 2026.

Filings a yearinsider forms included
1625076634440
2019202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 10 times in the last 36 months, the newest Oct 16, 2026.Listing warning from its exchange (8-K item 3.01): 1 time in the last 36 months, the newest Sep 2, 2026.SEC letters: 4 in the last 36 months, the newest Mar 12, 2025.
Insider forms 121

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 12, 2026 10-Q Quarterly report Sep 30, 2026
Nov 12, 2026 8-K items 2.02, 9.01 Results released · Current report
Oct 26, 2026 DEF 14A Proxy statement Nov 20, 2026
Oct 16, 2026 PRE 14A Preliminary proxy statement Nov 20, 2026
Oct 16, 2026 8-K item 5.02 Officer or director change · Current report Oct 13, 2026
Sep 30, 2026 8-K item 5.02 Officer or director change · Current report Sep 24, 2026
Sep 25, 2026 SCHEDULE 13G Large holder notice
Sep 11, 2026 8-K item 5.02 Officer or director change · Current report Sep 8, 2026
Sep 2, 2026 8-K items 2.05, 3.01, 5.02, 7.01, 8.01, 9.01 Exit or restructuring costs; Listing warning from its exchange; Officer or director change; Investor disclosure (Regulation FD); Other event · Current report Aug 27, 2026
Aug 18, 2026 8-K item 1.02 Major agreement ended · Current report Aug 12, 2026
Aug 14, 2026 SCHEDULE 13G/A Large holder update, amended
Aug 14, 2026 SCHEDULE 13G/A Large holder update, amended
Aug 12, 2026 10-Q Quarterly report Jun 30, 2026
Aug 12, 2026 8-K items 2.02, 9.01 Results released · Current report
Jun 22, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
May 22, 2026 8-K items 5.03, 5.07, 9.01 Charter, bylaw or fiscal-year change; Shareholder vote · Current report May 20, 2026
May 15, 2026 SCHEDULE 13G/A Large holder update, amended
May 6, 2026 10-Q Quarterly report Mar 31, 2026
May 6, 2026 8-K items 2.02, 9.01 Results released · Current report
Apr 17, 2026 ARS Annual report to shareholders Dec 31, 2025
Apr 17, 2026 DEF 14A Proxy statement May 20, 2026
Apr 7, 2026 PRE 14A Preliminary proxy statement May 20, 2026
Apr 2, 2026 8-K item 5.02 Officer or director change · Current report Mar 31, 2026
Mar 4, 2026 S-8 Employee stock plan registration
Mar 4, 2026 10-K Annual report Dec 31, 2025
Mar 4, 2026 8-K items 2.02, 9.01 Results released · Current report
Jan 12, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Nov 26, 2025 8-K item 5.02 Officer or director change · Current report Nov 25, 2025
Nov 12, 2025 10-Q Quarterly report Sep 30, 2025
Nov 12, 2025 8-K items 2.02, 9.01 Results released · Current report
Nov 3, 2025 8-K items 2.05, 7.01, 8.01, 9.01 Exit or restructuring costs; Investor disclosure (Regulation FD); Other event · Current report
Sep 9, 2025 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Aug 20, 2025 8-K item 5.02 Officer or director change · Current report Aug 14, 2025
Aug 14, 2025 SCHEDULE 13G/A Large holder update, amended
Aug 12, 2025 10-Q Quarterly report Jun 30, 2025
Aug 12, 2025 8-K items 2.02, 9.01 Results released · Current report
Aug 12, 2025 SCHEDULE 13G/A Large holder update, amended
Jul 16, 2025 SCHEDULE 13G/A Large holder update, amended
Jul 2, 2025 8-K item 5.07 Shareholder vote · Current report Jun 30, 2025
May 15, 2025 SCHEDULE 13G/A Large holder update, amended
40 of 215 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton TCRX · research, not advice